ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves Encorafenib, Cetuximab Combination for Metastatic Colorectal Cancer
April 10, 2020The U.S. Food and Drug Administration (FDA) approved encorafenib (BRAFTOVI, Array BioPharma) in combination with cetuximab for the treatment of adult patients ... -
FDA approves Pierre Fabre/Array Biotech melanoma combo
July 05, 2018US regulators have issued a green light for Pierre Fabre and Array Biotech’s encorafenib/binimetinib combination therapy for advanced BRAF-mutant melanoma.
Pharma Sources Insight January 2025
